Indrayani Biotech Limited (IBL) clocked a strong growth trajectory in FY23 with consolidated revenues of Rs 167 crore, as compared to revenue of Rs 62 crore in FY22. FY23 turned out to be a transformational year, with revenue growth of 171%. EBITDA margins also showed an upward trend. Indrayani reported…
Read More
Indrayani Biotech (BSE: 526445) is a growth stock that is likely to show strong double digit growth over the next few years. In its Annual Report released the last week, the company has projected a consolidated revenue of Rs 150 crore for FY23. In comparison, the revenue for FY22 was Rs…
Read More
The other day I was talking to a person who is an early-stage investor. He was looking to invest in a food business. He explained to me his criterion: he said his fund wanted to invest in a sales-multiple food business. This foxed me. I have heard of packaged food…
Read More
The data shared by the Union Government as part of the Budget process for fiscal 21-22 should allay concerns of those thinking that the new farm bills spell doomsday for farmers. The activists fronting for the farmers are claiming the government will do away with Minimum Support Price (MSP), stop…
Read More
An IPO of a company in the food business always arouses market interest. The IPO of Burger King India Limited opens next week. While going through the RHP, one data point struck us as interesting: since Burger King entered the market in India, it has matched WestLife Development for incremental…
Read More